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20 . Clinical aspects of orthotopic 
liver transplantation* 
Since the first orthotopic transplantation of the human liver was 
performed in Denver in 1963, 25 patients have had 26 such operations 
[19-29]. However, during the past 21 months, better understanding of 
histocompatibility matching, the addition of ALG to the immuno-
suppressive regimen, and the use of more adequately preserved homo-
grafts has made it possible to achieve more encouraging although still 
unsatisfactory results. 
Recipients 
The patients ranged in age from 12 months to 68 years. Thirteen were 
male and 12 female. The indication for transplantation was congenital 
biliary atresia in 13 cases, hepatoma with or without cirrhosis in 11, 
and alcoholic cirrhosis in one. One patient with biliary atresia received 
a second liver transplant 66 days following the initial operation, because 
of severe rejection of the homograft; he is still alive 7t months after the 
second operation. 
Donors 
Careful selection of donors was necessary. Any potential donor who 
had suffered from prolonged periods of hypotension and poor tissue 
perfusion was found to be unsuitable. lfthe liver from such a donor was 
used severe and persistent bleeding occurred and, in addition, more 
delayed effects of acute hepatic failure usually led to the death of the 
recipient. 
There were 21 male and 6 female donors, ranging in age from one to 
73 years. The majority died of acute head injuries or of non-traumatic 
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neurologic disorders. Prior to the death of the donor ABO grouping 
was determined. In later cases, histocompatibility matching, using the 
Terasaki technique, was utilized to select the best possible recipient 
from our waiting-list. 
With many of the adult donors the femoral vessels were cannulated, 
as soon as possible after death was pronounced, and partial cardio-
pulmonary bypass was instituted [14, 15, 19]. This provided satisfactory 
perfusion of the liver with oxygenated, cooled blood. Donor hepatec-
tomy was then performed. For pediatric donors, cardio-pulmonary by-
pass was usually not used but the superior mesenteric vein was rapidly 
cannulated and the liver was perfused with a cold electrolyte solution 
at a temperature of 2_40 C [19,29]. Egress for the perfusate was pro-
vided by making an opening in the inferior vena cava. 
On many occasions there was a considerable time interval between 
removal of the donor liver and completion of the recipient hepatectomy. 
Most often this delay was caused by a difficult recipient operation 
resulting from numerous adhesions and/or collateral channels. In these 
cases the liver was not immediately transplanted but was protected 
from ischaemia by perfusing it with diluted blood in a hyperbaric oxygen 
chamber, where it was exposed to oxygen at a pressure of 40 pounds 
per square inch, and maintained at a temperature of 4° C [5]. Thirteen 
livers were preserved under these conditions for periods ranging from 
61 minutes to 240 minutes [29]. With one exception all these livers 
functioned satisfactorily following revascularization in the recipient. 
The longest period of total hepatic ischaemia, from the death of the 
donor to revascularization in the recipient, was n- hours. This liver 
functioned well and the recipient is still alive more than 11 months 
after operation. 
The recipient operation 
Removal of the recipient liver involved severance of the structures 
entering and leaving the liver. The suprahepatic vena cava of the donor 
liver was anastomosed to the recipient vena cava, followed by the 
infrahepatic vena caval anastomosis. The portal venous and hepatic 
arterial reconstructions were then performed. Shunts to temporarily 
decompress the portal vein and vena cava during the performance of 
these anastomoses [18] have been found not to be necessary [29]. 
Following completion of the vascular anastomoses and restoration of 
blood-flow a cholecystoduodenostomy was the procedure of choice to 
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provide biliary drainage [23], except in the occasional case where the 
donor cystic duct ran parallel to the common bile duct and entered it 
very low down. There was a danger of accidentally ligating such a duct 
together with the common bile duct and thus obtaining no biliary 
drainage. Where this anatomic variation was recognized we removed the 
donor gall bladder and performed a choledocho-choledochostomy [29]. 
A splenectomy was usually performed not only for reasons of im-
munosuppression but also because pre-existing hypersplenism was 
common in these cases. 
Immunosuppression 
In the early cases immunosuppression was with Azothioprineand Predni-
sone only. However, it was found that there was practically no safety 
margin between effective and lethal doses of Azothioprine [21]. Subse-
quent experience bore out the fact that Azothioprine had to be given to 
human liver recipients in incongruously small doses [29]. Several factors 
were probably responsible. First, pre-existing liver disease may have 
depleted the patient's haemo- and lymphopoietic reserves. Second, the 
liver plays an important role in the detoxification of Azothioprine, and 
ischaemic or immunologic injury to the liver may have reduced its 
capacity to metabolize Azothioprine. In the presence of impaired liver 
function it was necessary to reduce the dosage of Azothioprine to prevent 
the complication of bone marrow depression. 
In the last 21 months we used triple drug therapy for immuno-
suppression-the two drugs mentioned above plus antilymphocyte 
globulin [22-25, 27-29]. The addition of the latter agent has consider-
ably improved our results of kidney transplantation [23, 26] and we 
believe that it is one of the agents responsible for long-term survival in 
liver transplantation. 
Initially ALG was used only for the first 4 months following liver 
transplantation. However, several patients showed the first evidence of 
rejection only when ALG therapy was discontinued and in our later 
cases ALG therapy has been prolonged for periods of up to 8 months [29]. 
Intra- and postoperative problems 
Physiologic considerations 
Apart from technical considerations the main problems encountered 
were concerned with maintenance of an adequate blood volume, 
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correction of acid-base abnormalities, and prevention of hypoglycaemia. 
The operation was often rather bloody because of pre-existing portal 
hypertension and because of the need to divide numerous vascular 
adhesions and collateral channels. Blood replacement kept pace with 
loss and fresh blood was preferred to avoid the hyperkaliaemia and 
acidosis which frequently complicate transfusions of stored blood. 
Metabolic acidosis was frequent during the anhepatic phase [1, 27] 
and was compounded by the administration of large quantities of ACD 
blood. Repeated estimations of arterial blood gases, pH and bicarbonate 
levels were necessary and abnormalities were corrected by the adminis-
tration of appropriate amounts of sodium bicarbonate. 
A fall in the blood sugar level had to be prevented during the anhepatic 
phase and during the early post-transplantation period. This complica-
tion occurred in the first postoperative hours in spite of the fact that 
other measures of hepatic function appeared to be adequate [1]. Hypo-
glycaemia was avoided by administering dextrose intravenously at the 
rate of 0·1-0·5 gm/kg per hour during surgery and afterwards. The 
blood glucose level was monitored at frequent intervals. 
Large quantities of ACD blood may produce direct myocardial 
depression even with perfect acid-base control. This effect was counter-
acted by the intermittent administration of 300 to 400 mgm of calcium 
gluconate or chloride intravenously [17, 32]. During the first few hours 
postoperatively the endotracheal tube was not removed. Ventilatory 
support was not discontinued until the patient began objecting to the 
presence of the endotracheal tube. Meticulous and frequent tracheo-
bronchial toilet was essential to prevent atelectasis and pneumonia. 
The serum electrolytes were monitored frequently as hypokaliaemia 
was frequent soon after transplantation, partly because of the removal 
of potassium from the circulation by the transplanted liver and partly 
because of the administration of large quantities of sodium bicarbonate 
to correct acidosis [12, 30]. 
Coagulation problems 
Haemorrhage. Intraoperative bleeding was copious in some cases. It 
was found necessary to quickly examine the entire operative field for 
major bleeding sites, particularly at the anastomoses. If no localized 
bleeding site was responsible then the cause was found to be a deficient 
clotting mechanism, the severity of which was roughly proportional to 
the magnitude of ischaemic injury to the liver. This resulted in intra-
vascular coagUlation associated with pathologic fibrinolysis [3, 4, 10, 11, 
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16] coupled with temporary cessation of the synthesis of proteins 
essential for coagulation [31]. Exhaustive efforts were made to secure 
mechanical haemostasis of capillary bleeders with suture ligatures and 
cautery. If bleeding persisted, the prevention of fatal haemorrhage 
required the use ofthrombogenic agents such as EACA, fibrinogen, and 
protamine sulphate. With better quality homografts, thrombogenic 
agents were unnecessary. Further, they could have potentiated the 
already significant risk of delayed intravascular thrombosis. 
Clotting. Thrombosis of the main hepatic artery occurred in one of 
our patients and in a patient treated by Birtch [2] of Boston. Both 
recipients died. In these 2 cases, superb liver grafts had been provided. 
The 'auto-anticoagulation' effect which follows hepatic ischaemia was 
probably thereby lost. Under optimal clinical circumstances of organ 
procurement and preservation, it may therefore be advisable to institute 
prophylactic anticoagulation after liver transplantation. 
A homograft with 2 hepatic arteries underwent partial gangrene 
within 48 hours of transplantation, when the anastomosis of the smaller 
right branch thrombosed. Resection of the necrotic liver was followed 
by survival for 4! months. 
Non-conventional arterial anastomoses were necessary in 2 patients 
with gross congenital vascular anomalies. Both arteries became pinched 
or kinked postoperatively but did not thrombose. However, both 
patients died in the early postoperative period of arterial insufficiency 
[29]. . 
Another patient died of portal vein thrombosis. 
Other complications 
Air embolism via tears which occurred in the inferior vena cava or its 
tributaries during recipient hepatectomy occurred in several cases but 
was symptomatic in only one patient [29]. 
Paralysis of the right diaphragm occurred in 4 patients as a result of 
including a portion of the diaphragm in the vascular clamp used to 
occlude the suprahepatic vena cava. In most cases this complication 
could be avoided by developing a longer vena caval cuff in the recipient 
and by taking care not to include any diaphragm in the bite of the 
vascular clamp. 
Gastro-intestinal ulceration or bleeding occurred in the early post-
operative period in patients who received poor-quality liver grafts. 
Later in the postoperative period gastro-intestinal bleeding occasionally 
occurred as a complication of high dosage steroid therapy. This usually 
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responded to conservative management and no patient required surgical 
treatment for the control of haemorrhage. 
Pulmonary embolism was encountered in 3 patients treated early in 
our experience [19, 20]. Possible causes of this complication were the 
use of venous bypass shunts and the administration of clot-promoting 
agents. After these practices were discontinued, there were no additional 
examples in the next 22 recipients. 
Arterial hypertension developed postoperatively in 3 patients. 
Abnormally high serum levels of norepinephrine and/or tyramine were 
found in 2 of the patients [29]. Probably tyramine degradation by the 
liver was depressed in at least some of the recipients. This agent is 
believed to exert a vasoconstrictor effect by causing release of norepine-
phrine from adrenergic nerve endings. 
Varieties of rejection 
Acute 
Rejection occurred in 1 of 3 forms-a mild subclinical type, an acute 
explosive variety, and an indolent, slowly progressive form [29]. The 
first 2 varieties were reversible with appropriate therapy, but the latter 
kind showed little tendency to regress. This latter variety presented 
with hepatomegaly and a picture resembling a slowly developing 
obstructive jaundice. The clinical picture in the two former types varied 
in degree and presented with several of the following features: anorexia, 
extreme fatiguability, back pain, hepatomegaly, light-coloured stools, 
dark urine, fever, leucocytosis, fluid retention with gain in weight, 
hyperbilirubinaemia, and elevation of the serum transaminase and 
alkaline phosphatase levels. In severe cases depression of the serum 
protein levels and of the liver-based clotting factors occurred. Serial 
scanning of the liver using 99 M-technetium was very helpful in making 
the diagnosis of rejection [9, 29]. In mild cases the scan showed enlarge-
ment of the liver. In more severe cases there was poor take-up of the 
isotope by the liver, or there was paradoxical decrease in size of the 
liver despite clinical evidence of hepatomegaly. 
Investigations in dogs [13] and pigs [7] have shown that hepatic 
rejection often underwent spontaneous resolution without any change 
in therapy or in some animals in the absence of any therapy at all. This 
experience initially caused us to adopt a policy towards hepatic rejection 
different from that which is standard practice in our institution after 
renal transplantation. When renal homografts undergo deterioration, 
ORTHOTOPIC LIVER TRANSPLANTATION 251 
steroid doses are invariably increased and maintained at whatever 
levels are necessary to restore good kidney function. With rejection in 
liver homografts we have often maintained steroid dosage at pre-existing 
levels or have even decreased the quantities. In several cases, episodes 
of acute rejection have reversed under these conditions. However, it is 
our present view that therapy should be intensified at these times. We 
now believe that adherence to a less aggressive therapeutic policy was 
probably the most important single etiologic factor in the septic hepatic 
infarctions to be mentioned below. 
Chronic 
It was mentioned earlier that the discontinuance of ALG treatment in 
the majority of patients was followed shortly afterwards by signs of 
delayed rejection. The pace of events with rejection occurring months 
after operation was relatively slow. The principal metabolic abnormali-
ties detected were those of progressive obstructive jaundice [29]. The 
process was exceedingly difficult or impossible to reverse despite signifi-
cant adjustments in immunosuppressive treatment. 
The consequences oflate rejection were ordinarily well tolerated since 
the functions of hepatic synthesis remained essentially intact. The two 
presently living patients in our series who have had the longest follow-
ups have been jaundiced for 8 and 10 months respectively. The total 
postoperative interval of observation in both instances now exceeds 
1 year. 
Septic hepatic infarction 
A special complication of rejection was the development of regional 
hepatic gangrene, which occurred in 5 consecutive cases early in our 
series [24, 25, 29]. This calamity probably resulted from a combination 
of factors-(a) acute rejection, with its concomitant decrease in blood 
flow through the liver, (b) lack of support of the transplanted organ, 
which caused rotation of the organ backwards and medially, with 
resultant kinking and thrombosis of the right hepatic artery, and (c) 
invasion of the infarcted area by intestinal micro-organisms [6]. The 
resulting septic infarct produced a triad of gram-negative septicaemia, 
markedly elevated serum transaminase levels, and the development on 
serial liver scans of large areas of persistently absent isotope concentra-
tion in the homograft. Treatment required early and extensive debride-
ment of dead liver tissue, drainage of the affected portion of liver and 
administration of the appropriate antibiotics. Despite these measures 
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4 of the 5 patients died soon after the development of this complication. 
We believe that the best treatment is prophylaxis. 
Prevention of this complication requires intensive immunosuppres-
sive therapy, especially during the early postoperative period to avoid 
rejection; fixation of the falciform and other ligaments of the homograft 
to the companion structures in the recipient to avoid distortion of the 
right hepatic artery, and administration of antibiotics for 1 or more 
weeks after the operation. Since these measures have been adopted we 
have not had any further cases of septic hepatic infarction. 
Infectious complications 
Increased susceptibility to infection is a problem common to the trans-
plantation of all organs as a result of lowering the reactivity of the host 
by the use of immunosuppressive drugs. The risk of infection was found 
to be disproportionately great after liver transplantation [8, 29], 
possibly because of a loss of the normal reticulo-endothelial function of 
bacterial filtration. In consequence, there may be greater permeability 
of the transplant to gastro-intestinal flora carried to it through the portal 
venous and biliary duct systems. It is also possible that depression of 
the reticulo-endothelial activity of the graft may undermine the total 
host defences against infection of other organ systems. Because of the 
environment in which the orthotopic transplant must exist it is obvious 
that antibiotic therapy against gram negative organisms is often required. 
Even in the case of well-functioning grafts episodes of bacteraemia 
were common while patients with poorly functioning transplants were 
particularly prone to infections especially septicaemia with gram negative 
organisms. Large doses of immunosuppressive drugs and prolonged 
use of antibiotic agents further increased the patient's susceptibility to 
infection. Important features of the infections encountered were a pre-
disposition to pneumonitis; a tendency for localized sepsis to become 
multifocal; and the frequent etiologic role of gram-negative bacteria, 
fungi, and other less common micro-organisms of normally low 
pathogenicity. 
Tumour recurrence 
In 3 of 4 patients, operated upon for hepatoma, metastases of the tumour 
made their appearance within 3 to 5 months of the transplant operation 
[29]. These were particularly prominent in the lungs, where massive 
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metastases ultimately developed. It is possible that microscopic pulmon-
ary metastases were present at the time of the transplant operation, and 
that the decreased host resistance induced by the immunosuppressive 
drugs permitted the tumour cells to flourish. In 3 of the patients the 
transplanted liver itself became the seat of metastatic deposits. 
Survival 
Of the 25 patients 14 lived for periods less than 8 weeks. Death in this 
early period resulted from several causes-the use of an organ damaged 
by ischaemia; technical problems which resulted in occlusion of the 
arterial or venous inflow of the liver; the use of large doses of immuno-
suppressive agents which resulted in overwhelming infection; and fatal 
pulmonary embolism. 
Eleven patients survived for periods of 8 weeks or longer. Seven of 
these patients survived more than 6 months and 3 survived more than 
1 year [29]. At present 7 patients are alive 13, 12, 11, 10, 8, 6 and 1 
month post transplant respectively. Of these patients 2 have reached 
the terminal stages of metastatic hepatoma; 3 have chronic rejection 
but are otherwise in satisfactory general condition; and 1 has intra-
abdominal complications following his transplant operation 1 month 
ago. Only 1 patient, a 4 year-old-boy, who had a transplant performed 
8 months ago for biliary atresia, is in perfect health. 
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